Our multiparametric analysis revealed a distinct clustering of intestinal and nonintestinal subtypes of IPMN, primarily influenced by differences in MUC1, MUC2, IL‐18, and IL‐18BP protein expression. The gene discussed is MUC1; the disease is pancreatic intraductal papillary-mucinous neoplasm.